Evidence map›Paper›PMID 29374149›Full record

ArticleCell death & disease2018

FLI1 and PKC co-activation promote highly efficient differentiation of human embryonic stem cells into endothelial-like cells.

Hao Zhao, Yan Zhao, Zili Li, Qi Ouyang, Yi Sun, Di Zhou, Pingyuan Xie, Sicong Zeng, Lingfeng Dong, Hua Wen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hao ZhaoInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Yan ZhaoNational Engineering & Research Center of Human Stem Cells, Changsha, China.
Zili LiNational Engineering & Research Center of Human Stem Cells, Changsha, China.
Qi OuyangInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Yi SunInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Di ZhouInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Pingyuan XieInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Sicong ZengInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Lingfeng DongInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Hua WenInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Guangxiu LuInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Ge LinInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China.
Liang HuInstitute of Reproduction & Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha, China. lianghu7@gmail.com.ORCID 0000-0001-6984-834X
Central South University · CNNational Engineering Research Center of Human Stem Cells · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale-endothelial cells (ECs) play important roles in various regeneration processes and can be used in a variety of therapeutic applications, such as cardiac regeneration, gene therapy, tissue-engineered vascular grafts and prevascularized tissue transplants. ECs can be acquired from pluripotent and adult stem cells. To acquire ECs from human embryonic stem cells (hESCs) in a fast, efficient and economic manner. We established a conditional overexpression system in hESCs based on 15 transcription factors reported to be responsible for hematopoiesis lineage. Among them, only overexpression of FLI1 could induce hESCs to a hematopoietic lineage. Moreover, simultaneous overexpression of FLI1 and activation of PKC rapidly and efficiently induced differentiation of hESCs into induced endothelial cells (iECs) within 3 days, while neither FLI1 overexpression nor PKC activation alone could derive iECs from hESCs. During induction, hESCs differentiated into spindle-like cells that were consistent in appearance with ECs. Flow cytometric analysis revealed that 92.2-98.9% and 87.2-92.6% of these cells were CD31+ and CD144+, respectively. Expression of vascular-specific genes dramatically increased, while the expression of pluripotency genes gradually decreased during induction. iECs incorporated acetylated low-density lipoproteins, strongly expressed vWF and bound UEA-1. iECs also formed capillary-like structures both in vitro and in vivo. RNA-seq analysis verified that these cells closely resembled their in vivo counterparts. Our results showed that co-activation of FLI1 and PKC could induce differentiation of hESCs into iECs in a fast, efficient and economic manner.

Indexed as

Cell DifferentiationAnimalsCell LineCell LineageCellular ReprogrammingEndothelial CellsEnzyme ActivationHematopoiesisHuman Embryonic Stem CellsHumansMaleMice, Inbred BALB CMice, NudeProtein Kinase CProtein Kinase InhibitorsProto-Oncogene Protein c-fli-1FLI1 protein, humanProtein Kinase CProtein Kinase InhibitorsProto-Oncogene Protein c-fli-1

Identifiers

PMID29374149
PMCPMC5833666
OpenAlexW2792610985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.